Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Preclinical studies have shown the potential antitumour efficacy of monoclonal antibodies (MAbs) directed to the epidermal growth factor receptor (EGFR). In this report, we investigated the cytotoxic effects of the MAb matuzumab (EMD 72000) towards A431 cells and compared it to cetuximab. While cetuximab induced cell cycle arrest and inhibited A431 cell proliferation, matuzumab did not. Both MAbs inhibited growth factor induced EGFR, HER2 and AKT phosphorylation; however, only cetuximab inhibited ERK 1/2 phosphorylation. Taken together, the data indicate that each antibody may elicit different responses on EGFR downstream signalling pathways with a distinct impact on A431 cell line survival. When combined, MAbs synergistically inhibited cell proliferation and induced EGFR down-regulation with a strong inhibition of ERK1/2 and AKT phosphorylation. In addition, both MAbs efficiently inhibited VEGF expression and induced ADCC, highlighting their therapeutic potential in vivo when used either as a single agent or in combination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejca.2008.12.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corticotropin-Releasing Hormone in Melanoma and Nonmelanoma Skin Cancer.
J Skin Cancer
August 2025
Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany.
Corticotropin-releasing hormone (CRH) regulates immunological and cellular processes. Recently, CRH is expressed in skin cancers, where its expression appears to correlate with the degree of malignancy. This study correlates CRH expression in melanoma metastases with patient survival and compares the intensity of CRH expression in melanoma to that in less aggressive skin cancer entities.
View Article and Find Full Text PDFCyclodextrins grafted magnetite (FeO) nanocarriers for anticancer therapy.
Drug Metab Rev
September 2025
Department of Chemistry, Faculty of Science, Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya (Deemed to be University) (SCSVMV), Kanchipuram, India.
This comprehensive review explores the therapeutic promise of cyclodextrin-grafted magnetite (FeO) nanocarriers in anticancer applications, focusing on their design, drug delivery mechanisms, biological stability, and therapeutic performance. Systems integrating cyclodextrins (cds) with FeO nanoparticles (FeO-cd-drug) have been developed for delivery of key anticancer agents such as docetaxel, irinotecan, paclitaxel, and doxorubicin across 11 cancer cell types. Results demonstrate up to 60% reduced cancer cell viability when using magnetite nanoparticle (FeO-np)-cds-docetaxel/irinotecan/doxorubicin systems compared to the pristine drug.
View Article and Find Full Text PDFElectrospun poly(3-hydroxybutyrate) fibers containing pheophorbide derivatives: Structural, photophysical, and photodynamic properties for anticancer applications.
Colloids Surf B Biointerfaces
December 2025
Department of Biological and Chemical Physics of Polymers, Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Kosygina ul. 4, Moscow 119334, Russian Federation; Academic Department of Technology and Chemistry of Innovative Materials, Plekhanov University of Economics, Stremyanny
The study explores novel electrospun poly(3-hydroxybutyrate) (PHB) systems for pheophorbide derivative (PheoD) photosensitizers delivery in anticancer photodynamic therapy (PDT). The photophysical properties of PheoD within PHB matrix and the resulting impact on polymer morphology (SEM, AFM), supramolecular structure (XRD, EPR), mechanical behavior, in vitro release, cytotoxicity assay on A431 cells, and antimicrobial properties were investigated. It was shown, that the difference in the PheoD's radical does not affect PHB's semicrystalline nature and amorphous region's structure but causes significant changes in the morphological characteristics of the surface.
View Article and Find Full Text PDFBioactive Potential of Flower Extracts: Antidiabetic, Anti-Skin Aging, Cytotoxic, and Dihydroorotase-Inhibitory Activities.
Plants (Basel)
August 2025
Department of Biomedical Sciences, Chung Shan Medical University, Taichung City 402, Taiwan.
Carnivorous plants have garnered attention as sources of pharmacologically active compounds, yet their floral tissues remain largely underexplored. In this study, we investigated the bioactive properties of flower extracts prepared using water, methanol, ethanol, and acetone. Among these, the ethanol extract exhibited the highest total phenolic content (18.
View Article and Find Full Text PDFDual T/NK cell engagement via B7-H6-targeted bispecific antibodies and IL-15 eradicates chemo-resistant solid tumors.
Front Immunol
August 2025
College of Biomedicine and Health, Huazhong Agricultural University, Wuhan, Hubei, China.
Introduction: B7-H6, a tumor-specific immune checkpoint molecule within the B7 family, represents a promising therapeutic target due to its selective overexpression in malignancies and negligible expression in normal tissues.
Method: Here, we developed bispecific antibodies (BsAbs) targeting B7-H6 to redirect T and NK cells against solid tumors. Through phage display, 15 high-affinity B7-H6 monoclonal antibodies were generated.